8-K: Gold Flora Reports $31.6 Million in Q2 Revenue, Achieves 57% Adjusted Gross Margin

Gold Flora Corporation announced its Q2 2024 financial results, reporting $31.6 million in revenue and a 57% adjusted gross margin, while also achieving its goal of 30% retail revenue from first-party brands.

Summary

• Gold Flora Corporation reported a total revenue of $31.6 million for the second quarter of 2024.
• The company achieved a gross profit of $7.2 million, representing a 23% gross margin.
• Adjusted gross profit was $18.2 million, resulting in a 57% adjusted gross margin.
• The company experienced a net loss of $24.0 million for the quarter.
• Adjusted EBITDA was a loss of $2.0 million for the quarter.
• Cash used in operating activities was $4.8 million.
• The company had $10.7 million in cash and cash equivalents as of June 30, 2024.
• Gold Flora met its goal of generating over 30% of retail revenue from its first-party brand portfolio.
• The company has expanded its cultivation footprint by leasing an additional 53,000 square feet, expecting to add 25,000 pounds of annual flower production.
• Flower harvest volume increased by 14% compared to the previous quarter.
• The Gramlin brand is now the 5th fastest growing cannabis brand in California.

Sentiment

Score: 5

Explanation: The document presents a mixed picture with strong adjusted gross margins and brand growth offset by significant net losses and negative EBITDA. The expansion plans are positive, but the current financial performance is concerning.

Positives

• The company achieved a strong adjusted gross margin of 57%.
• Gold Flora successfully met its goal of generating 30% of retail revenue from its own brands.
• Cultivation improvements resulted in a 14% increase in flower harvest volume.
• The company is expanding its cultivation capacity, which is expected to increase flower production by 25,000 pounds annually.
• The Gramlin brand is experiencing rapid growth in the California market.
• The company's Form-211 cleared the U.S. securities regulatory process, removing restrictions on its U.S. market activity.

Negatives

• The company reported a net loss of $24.0 million for the quarter.
• Adjusted EBITDA was a loss of $2.0 million.
• Cash used in operating activities was $4.8 million.
• Total revenue decreased by 2% compared to the previous quarter.

Risks

• The company is operating in a competitive and evolving California cannabis market.
• The company is reliant on obtaining necessary state and local licenses for its expanded cultivation facilities.
• The company is experiencing a net loss and negative adjusted EBITDA.
• The company is subject to risks associated with forward-looking statements, including the expected increase in flower production.

Future Outlook

The company expects to increase flower production by 25,000 pounds annually with the expansion of its cultivation facilities and anticipates continued growth in the second half of 2024.

Management Comments

• Laurie Holcomb stated that the company's vertically integrated operations have allowed them to expand their competitive position and enhance their brand portfolio.
• Ms. Holcomb highlighted the company's ability to bring high-quality, high-margin products to market.
• Ms. Holcomb noted that the company's cultivation investments are complete and subsequent harvests are demonstrating improved yield and product quality.

Industry Context

This announcement reflects the ongoing challenges and opportunities in the California cannabis market, where companies are focusing on vertical integration, brand development, and efficient operations to achieve profitability. Gold Flora's focus on its own brands and cultivation capacity aligns with industry trends.

Comparison to Industry Standards

• While Gold Flora's adjusted gross margin of 57% is strong, it is important to compare this to other vertically integrated cannabis companies in California such as Cresco Labs, which has reported gross margins in the 40-50% range, and Curaleaf, which has reported similar gross margins.
• The company's net loss of $24 million is significant and needs to be compared to the losses of other cannabis companies in the same market, such as Trulieve, which has also reported losses but has a larger revenue base.
• The expansion of cultivation capacity is a common strategy in the industry, with companies like Canopy Growth and Aurora Cannabis also investing heavily in cultivation facilities, although these companies are in different markets.

Management Changes

Stakeholder Impact

• Shareholders may be concerned about the net loss and negative EBITDA.
• Employees may be impacted by the company's performance and future growth plans.
• Customers may benefit from the company's focus on high-quality products and brand expansion.
• Suppliers may see increased demand as the company expands its cultivation capacity.
• Creditors may be concerned about the company's financial performance.

Next Steps

• The company will host a conference call to discuss the Q2 2024 financial results on August 14, 2024.
• The company will continue to expand its Gramlin product line.
• The company will focus on integrating the new cultivation facilities and increasing flower production.
• The company will file its Annual Report on Form 10-K on EDGAR and SEDAR.

Key Dates

Keywords

cannabis, financial results, revenue, gross margin, cultivation, retail, EBITDA, Gramlin, California, flower harvest